New Under-the-Tongue allergy shot could replace needles
NCT ID NCT07210320
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called l-dipivefrin (IN-001) given under the tongue as a spray or drops, compared to standard epinephrine injections, in 32 healthy adults. The goal was to see how the body absorbs the drug and its safety. It is an early-stage study to gather information, not to treat a disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAPHYLAXIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University in St. Louis School of Medicine
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Mother's diet during pregnancy prevent peanut and egg allergies in her baby?
- Are allergy pens long enough? study measures thigh depth to find out
- AI tool aims to cut allergy misdiagnosis in primary care
- Can a shot help people with high IgE eat more foods safely?
- Can allergy drugs help kids tolerate peanut and more?
- Peanut allergy breakthrough? new study tests daily dosing to build tolerance in kids